Global Alpha Capital Adds Another $15 Million to Its 7th-Largest Position: Genius Sports

Global Alpha Capital increased its stake in Genius Sports by 537,900 shares (~$15.05m) in a 13F filing dated Nov. 12, 2025, raising its holding to 4,733,700 shares valued at $58.6m (3.35% of reportable AUM) and making Genius its seventh-largest position; the transaction represented roughly 0.37% of the fund’s 13F AUM. Genius Sports, which closed at $10.75 on Dec. 9, 2025, has TTM revenue of $604.5m, a net loss of $119.2m and a $2.57bn market cap, delivered ~38% revenue growth last quarter and holds commercial and integrity contracts with major leagues (including an NFL stake), but remains unprofitable. The incremental buy—coming after a prior quarter accumulation and a ~20% price rise—signals institutional conviction in the company’s role as a “picks-and-shovels” provider to the sports-betting ecosystem, though margin expansion and profitability are key execution risks.

Analysis

Global Alpha Capital disclosed a purchase of 537,900 Genius Sports (GENI) shares in a Nov. 12, 2025 13F filing, adding roughly $15.05 million and bringing its total to 4,733,700 shares valued at $58.60 million. The position now represents 3.35% of the fund's 13F-reportable AUM and is its seventh-largest holding; the incremental buy equated to ~0.37% of reportable AUM and followed earlier accumulation that left GENI a 2.7% position the prior quarter.

Genius Sports trades at $10.75 (Dec. 9, 2025), up 11% year-over-year, with TTM revenue of $604.52 million and a TTM net loss of $119.17 million; the company reported ~38% revenue growth in its most recent quarter but remains unprofitable. Key structural positives include partnerships with major leagues (EPL, NCAA, NBA) and an NFL 10% stake, while margin pressure is evident: stock-based compensation equals ~24% of revenue and the stock trades at ~36x forward earnings.

The trade signals institutional conviction in GENI’s “picks-and-shovels” role for sports betting, supporting mildly positive sentiment, but execution risk is material—profitability, margin expansion, and retention/renewal of league and sportsbook contracts must improve to validate the current valuation. Investors should treat the buy as a signal of growth conviction rather than de-risked earnings proof and watch near-term operational KPIs.

Key Decisions for Investors

• Consider a modest, conviction-weighted exposure to GENI reflecting institutional interest, but cap position sizes given the company’s TTM net loss and 36x forward earnings valuation
• Monitor quarterly indicators—revenue growth trajectory, EBITDA/profitability trends, reduction in stock-based compensation as a percentage of revenue, and contract renewals with major leagues (NFL, EPL)—and increase exposure only if margins visibly improve
• If management fails to deliver margin expansion or meaningful progress toward profitability over the next 2–3 quarters, consider trimming or hedging the position to protect against downside given valuation sensitivity